FDA, Shortage and Weight-Loss Drug
The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
5don MSN
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
Contaminated food is causing a growing number of illnesses in the United States, and severe cases that lead to ...
Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...
Explore how recent layoffs at the FDA and NIH under the Trump Administration could hinder medical innovation and public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results